LDL Chol Calc (NIH): What Your LDL Cholesterol Result Means

At a Glance

LDL-C is the cholesterol carried in low-density lipoprotein particles, reported in mg/dL (or mmol/L). On many standard lipid panels, including Labcorp's, it is calculated from the other results, not measured directly. Labcorp's lipid panel lists it as "low-density lipoprotein (LDL) cholesterol (calculation)" and prints it as "LDL Chol Calc (NIH)".

The interval stored on this page is 0 to 99 mg/dL, the interval Labcorp's sample lipid report prints for the same line, and every result here is flagged against it.

A reference interval is only half of the reading. The 2026 ACC/AHA dyslipidemia guideline sets LDL-C goals that depend on your cardiovascular risk and situation: below 100, below 70 or below 55 mg/dL, as set out below.

What "Calc (NIH)" means on your report

"Calc" means the laboratory worked out your LDL-C from the rest of the lipid panel rather than measuring it. "NIH" refers to the NIH equation, published by Sampson and colleagues in 2020 and developed using data from patients at the National Institutes of Health Clinical Center; the laboratory trade journal CAP Today reported in 2020 that Labcorp had switched its calculated LDL-C to this new equation. According to its authors, it uses triglycerides and non-HDL cholesterol (total cholesterol minus HDL cholesterol) to estimate LDL-C, and it "calculates the LDL-C level in patients with TG levels up to 800 mg/dL as accurately as the Friedewald equation does for TG levels less than 400 mg/dL."

The older Friedewald equation had been the standard since 1972. The 2026 ACC/AHA guideline now states that "use of either the Martin/Hopkins equation or the Sampson/NIH equation is preferred over calculation by the Friedewald equation to estimate LDL-C", because they "provide greater accuracy across a wide range of LDL-C and TG levels." The guideline also prefers these equations over direct LDL-C measurement, except the reference beta-quantification method, noting that direct assays are limited by insufficient standardization.

So "LDL Chol Calc (NIH)" is not a different test and not a lesser one. It is LDL-C, calculated by the method the current guideline prefers.

When it cannot be calculated. Labcorp states that "LDL cholesterol cannot be calculated if triglyceride is >800 mg/dL." If your report shows no LDL value, one reason is very high triglycerides.

The two numbers: interval and goal

The reference interval (0–99 mg/dL, here and at Labcorp) is what the flag uses. On this page the same interval applies to every result.

The goal, where one applies, is set for you by your clinician, using your overall cardiovascular risk. In the 2026 ACC/AHA guideline:

For people without heart disease or diabetes, the guideline describes these goals as reasonable rather than required.

The 10-year risk is estimated with the American Heart Association's PREVENT equations, which the guideline uses for adults aged 30 to 79 without known cardiovascular disease and with LDL-C between 70 and 189 mg/dL. Labcorp's current lipid report prints the primary-prevention part of this table beneath the result.

For people at low risk (under 3%) with LDL-C below 160 mg/dL and, for people aged 30–59, a 30-year risk below 10%, the guideline recommends counseling on health behaviors rather than setting a numeric goal.

How to read your result

These steps read a single adult LDL-C result, reported as a whole number. Which goal, if any, applies to you is for your clinician to say.

Below 55 mg/dL. Inside the interval. Below every goal in the 2026 guideline, including the lowest, used for most people with cardiovascular disease.

55 to under 70 mg/dL. Inside the interval. Meets a below-70 goal; above the below-55 goal used for most people with cardiovascular disease.

70 to under 100 mg/dL. Inside Labcorp's interval and the interval here. Meets a below-100 goal; above the below-70 goal used for high-risk groups.

100 to under 160 mg/dL. Flagged high here, as on a Labcorp report. Does not meet a below-100 goal. Whether anything needs to change depends on your 10-year risk, which this number alone cannot tell you.

160 to 189 mg/dL. Flagged high here. The guideline singles out this range: even in adults at low 10-year risk, a moderate-intensity statin is described as reasonable at an LDL-C of 160 to 189 mg/dL, and its first take-home message calls for early consideration of treatment in young adults with LDL-C of 160 or more.

190 mg/dL or above. Flagged high here. The guideline calls this severe hypercholesterolemia and treats it as its own category, outside the PREVENT risk calculation, with its own goals of below 100, 70 or 55 mg/dL depending on the situation. It notes that genetic testing for familial hypercholesterolemia can be useful when no secondary cause is found.

If you remember only one thing

"LDL Chol Calc (NIH)" is your LDL cholesterol, calculated with the method the current guideline prefers. Read it against your laboratory's interval for the flag, and against your risk-based goal for what it means for you.

Two people, same result

Two adults are each told their LDL Chol Calc (NIH) is 95 mg/dL.

The first is 45, has no heart disease, and has a 10-year PREVENT risk in the borderline range. If a statin has been started, the guideline describes a goal below 100 mg/dL as reasonable, so 95 meets it.

The second had a heart attack and is at very high risk. The guideline recommends a goal below 55 mg/dL for her. The same 95, unflagged on both reports, is well above her goal.

Same number, same flag, different meaning. The flag says where the number sits in the laboratory's interval; the goal depends on the person.

What this result cannot tell you

It cannot tell you your cardiovascular risk. That needs the PREVENT calculation, which uses more than your LDL-C.

It cannot tell you whether you need treatment. The guideline bases that on risk category and, for people with heart disease, on how high their risk is.

It cannot tell you about particle number or Lp(a). The guideline adds apolipoprotein B testing in some people once LDL-C goals are met, and recommends measuring lipoprotein(a) at least once in adulthood.

Common interpretation mistakes

Thinking "Calc (NIH)" is a lesser test than a "direct" LDL. The 2026 guideline prefers the Sampson/NIH equation over direct LDL-C measurement, except the reference beta-quantification method.

Assuming "NIH" means the Friedewald formula. They are different equations; the guideline prefers Sampson/NIH or Martin/Hopkins over Friedewald.

Reading an unflagged result as "at goal". A 95 is inside the interval, and above the goal for people at high or very high risk.

Using an older risk table. The 2026 guideline replaced the Pooled Cohort Equations with PREVENT and brought back LDL-C goals; tables based on the older equations are out of date.

Assuming you had to fast. The guideline says nonfasting samples can be used for most people; fasting is for those with a family history of dyslipidemia or premature cardiovascular disease, a known or suspected triglyceride disorder, or a nonfasting triglyceride level of 400 mg/dL or more.

Questions your doctor may ask

Whether you have had a heart attack, stroke or other cardiovascular disease. Whether you have diabetes or chronic kidney disease. Whether a parent or sibling had early heart disease or very high cholesterol. Whether you were fasting, and what your triglycerides were. And whether you already take a cholesterol-lowering medicine.

Read together with

Triglycerides, because the calculation depends on them and fails above 800 mg/dL. HDL cholesterol and total cholesterol, which give non-HDL cholesterol, the second goal in the guideline table. Where measured, apolipoprotein B and lipoprotein(a).

Clinical pearls

Most samples do not need fasting. The guideline states that because fasting and nonfasting LDL-C levels have similar prognostic value, nonfasting samples can be used for most people. It recommends a fasting profile for people with a family history of dyslipidemia or premature cardiovascular disease, a known or suspected triglyceride disorder, or a nonfasting triglyceride level of 400 mg/dL or more.

Timing after a heart attack matters. Labcorp notes that lipid panels are best avoided for three months after an acute heart attack, although cholesterol can be measured in the first 24 hours.

The older calculation was most fragile where it matters most. The guideline notes the Friedewald equation becomes less accurate as triglycerides rise and as LDL-C falls, which is where the newer equations do better.

Clinical Takeaway

"LDL Chol Calc (NIH)" is LDL cholesterol calculated with the Sampson/NIH equation, which the 2026 ACC/AHA guideline prefers over the older Friedewald formula. The flag compares it with the laboratory's interval (0–99 mg/dL, here and at Labcorp). The goal that matters for you, if one applies (below 100, 70 or 55 mg/dL in the guideline), depends on your cardiovascular risk, and 190 mg/dL or more is a category of its own.

In one sentence

Your LDL Chol Calc (NIH) is calculated, not measured, by the preferred method; read the flag against the lab interval and the meaning against your risk-based goal.

Bottom line

Check the flag, then ask which goal applies to you. A result inside the interval can still be above a goal set for people at higher risk.

LDL-C

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →

Beyond LDL-C — 10,000+ markers explained

One LDL-C result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.

Start with this report →

Frequently Asked Questions